Dr. Reddy's Laboratories
RDY
#1699
Rank
S$15.91 B
Marketcap
S$19.09
Share price
2.62%
Change (1 day)
8.50%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : S$2.47 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are S$2.47 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31S$1.47 B-19.44%
2022-03-31S$1.82 B7.94%
2021-03-31S$1.69 B16.2%
2020-03-31S$1.45 B-12.38%
2019-03-31S$1.66 B-16.75%
2018-03-31S$1.99 B-3.28%
2017-03-31S$2.06 B28.13%
2016-03-31S$1.61 B-12.12%
2015-03-31S$1.83 B9.78%
2014-03-31S$1.67 B5.01%
2013-03-31S$1.59 B3.79%
2012-03-31S$1.53 B10.69%
2011-03-31S$1.38 B18.64%
2010-03-31S$1.16 B-6.55%
2009-03-31S$1.24 B-5.67%
2008-03-31S$1.32 B-15.23%
2007-03-31S$1.56 B-8.35%
2006-03-31S$1.70 B437.5%
2005-03-31S$0.31 B47.02%
2004-03-31S$0.21 B139.76%
2003-03-31S$89.92 M15.88%
2002-03-31S$77.59 M-46%
2001-03-31S$0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
S$101.89 B 4,024.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$148.04 B 5,892.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$86.93 B 3,418.74%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
S$90.57 B 3,566.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$41.09 B 1,563.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel